• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体结构和脂质组成对含胞壁酰二肽脂质体激活巨噬细胞杀肿瘤特性的影响。

Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.

作者信息

Schroit A J, Fidler I J

出版信息

Cancer Res. 1982 Jan;42(1):161-7.

PMID:7053846
Abstract

Various vesicle structures and lipid compositions have been studied to identify the optimal type of liposome for delivery of the macrophage-activating agent muramyl dipeptide (MDP) to macrophages. Evaluation of the ability of liposomes to be phagocytosed by macrophages established that optimal initial rates of engulfment were obtained when multilamellar vesicles (MLV) composed of distearoylphosphatidylcholine (18:0 PC): phosphatidylserine (PS) (7:3 mol ratio) were used. MLV composed exclusively of 18:0 PC were phagocytosed at rates greater than or equal to those of MLV composed of egg phosphatidylcholine (PC):PS, whereas MLV composed only of egg PC were very poorly phagocytosed. Although phagocytosis was enhanced by incorporation of PS into MLV, the inclusion of PS brought about significant enhancement in liposome permeability in the presence of serum. The inclusion of PS, however, was a requirement for the delivery of MLV to the lungs following i.v. injection into mice whether used in conjunction with 18:0 PC or egg PC. Activation of macrophages to become tumoricidal against syngeneic tumor cells wtih liposome-encapsulated MDP was superior in both degree and duration when MLV composed of 18:0 PC:PS (7:3 mol ratio) were used. MLV were found to be superior to large unilamellar vesicles containing equal amounts of lipid and entrapped MDP. On the other hand, higher levels of macrophage activation were obtained when an equivalent amount of a lipophilic MDP derivative, muramyltripeptide:phosphatidylethanolamine, was incorporated into the liposome bilayer irrespective of whether the adjuvant was incorporated in liposomes composed of 18:0 PC:PS or egg PC:PS.

摘要

为了确定用于将巨噬细胞激活剂胞壁酰二肽(MDP)递送至巨噬细胞的最佳脂质体类型,人们研究了各种囊泡结构和脂质组成。对脂质体被巨噬细胞吞噬能力的评估表明,当使用由二硬脂酰磷脂酰胆碱(18:0 PC):磷脂酰丝氨酸(PS)(摩尔比7:3)组成的多层囊泡(MLV)时,可获得最佳的初始吞噬速率。仅由18:0 PC组成的MLV的吞噬速率大于或等于由蛋黄磷脂酰胆碱(PC):PS组成的MLV,而仅由蛋黄PC组成的MLV的吞噬能力非常差。虽然将PS掺入MLV可增强吞噬作用,但在血清存在下,PS的加入会导致脂质体通透性显著增强。然而,无论与18:0 PC还是蛋黄PC联合使用,PS的加入都是静脉注射到小鼠体内后将MLV递送至肺部的必要条件。当使用由18:0 PC:PS(摩尔比7:3)组成的MLV时,用脂质体包裹的MDP激活巨噬细胞使其对同基因肿瘤细胞具有杀瘤活性,在程度和持续时间上均更优。发现MLV优于含有等量脂质和包裹MDP的大单层囊泡。另一方面,当将等量的亲脂性MDP衍生物胞壁酰三肽:磷脂酰乙醇胺掺入脂质体双层中时,无论佐剂是掺入由18:0 PC:PS还是蛋黄PC:PS组成的脂质体中,均可获得更高水平的巨噬细胞激活。

相似文献

1
Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.脂质体结构和脂质组成对含胞壁酰二肽脂质体激活巨噬细胞杀肿瘤特性的影响。
Cancer Res. 1982 Jan;42(1):161-7.
2
Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.人肺泡巨噬细胞:脂质体包裹的胞壁酰二肽增强其杀肿瘤活性。
J Immunol. 1982 Sep;129(3):1313-7.
3
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.设计脂质体以改善巨噬细胞增强剂向肺泡巨噬细胞的递送。
Cancer Res. 1980 Dec;40(12):4460-6.
4
Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.含有胞壁酰二肽的脂质体对增强人肺泡巨噬细胞杀肿瘤活性的潜在价值。
J Biol Response Mod. 1984;3(2):185-94.
5
In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.游离或脂质体包裹的胞壁酰二肽对大鼠肝脏巨噬细胞进行体外激活使其具有杀肿瘤活性。
Cancer Res. 1986 Sep;46(9):4330-5.
6
Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.含有新型亲脂性胞壁酰二肽衍生物的冻干脂质体激活肺泡巨噬细胞的杀肿瘤活性并消除实验性转移灶。
Cancer Res. 1985 Jan;45(1):128-34.
7
Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.脂质体包裹的淋巴因子与胞壁酰二肽之间的协同作用:巨噬细胞的原位激活及自发性癌转移的治疗
J Immunol. 1984 Jul;133(1):515-8.
8
The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.脂质体包裹的免疫调节剂对内毒素反应小鼠和无反应小鼠巨噬细胞杀肿瘤特性的激活作用。
J Reticuloendothel Soc. 1983 Mar;33(3):165-74.
9
Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.从经含胞壁酰二肽亲脂性衍生物的脂质体全身治疗的小鼠肺黑色素瘤转移灶中分离杀肿瘤巨噬细胞。
J Natl Cancer Inst. 1982 Nov;69(5):1198-98.
10
Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.脂质体包裹的重组小鼠或人γ干扰素对巨噬细胞杀肿瘤特性激活的种属特异性消除。
J Immunol. 1985 Dec;135(6):4289-96.

引用本文的文献

1
Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.基于碳水化合物的化合物的治疗应用:医学进步的甜蜜解决方案。
Mol Divers. 2024 Dec;28(6):4553-4579. doi: 10.1007/s11030-024-10810-2. Epub 2024 Mar 30.
2
Etiology of lipid-laden macrophages in the lung.肺内富含脂质的巨噬细胞的病因。
Int Immunopharmacol. 2023 Oct;123:110719. doi: 10.1016/j.intimp.2023.110719. Epub 2023 Aug 16.
3
Carbohydrate-based drugs launched during 20002021.2000年至2021年期间推出的碳水化合物类药物。 (你提供的原文“20002021”表述有误,推测应该是“2000 - 2021” )
Acta Pharm Sin B. 2022 Oct;12(10):3783-3821. doi: 10.1016/j.apsb.2022.05.020. Epub 2022 May 23.
4
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins.通过将核酸、肽和蛋白质递送至细胞内来挖掘生物大分子的治疗潜力。
Adv Healthc Mater. 2022 Jun;11(12):e2102600. doi: 10.1002/adhm.202102600. Epub 2022 Mar 23.
5
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.脂质体作为药物传递系统的综述:已批准产品的现状、监管环境和未来展望。
Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372.
6
Muramyl Tripeptide-Phosphatidyl Ethanolamine Encapsulated in Liposomes (L-MTP-PE) in the Treatment of Osteosarcoma.脂质体包裹的 muramyl 三肽-磷脂酰乙醇胺(L-MTP-PE)治疗骨肉瘤。
Adv Exp Med Biol. 2020;1257:133-139. doi: 10.1007/978-3-030-43032-0_11.
7
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma.固有免疫细胞:治疗骨肉瘤的一种有潜力和有前途的细胞群体。
Front Immunol. 2019 May 16;10:1114. doi: 10.3389/fimmu.2019.01114. eCollection 2019.
8
Synergic modulation of the inflammatory state of macrophages utilizing anti-oxidant and phosphatidylserine-containing polymer-lipid hybrid nanoparticles.利用抗氧化剂和含磷脂酰丝氨酸的聚合物-脂质杂化纳米颗粒对巨噬细胞炎症状态进行协同调节。
Medchemcomm. 2017 Jun 2;8(7):1514-1520. doi: 10.1039/c7md00174f. eCollection 2017 Jul 1.
9
Managing sarcoma: where have we come from and where are we going?肉瘤的管理:我们从何而来,又将走向何方?
Ther Adv Med Oncol. 2017 Oct;9(10):637-659. doi: 10.1177/1758834017728927. Epub 2017 Sep 20.
10
The immunotherapy of canine osteosarcoma: a historical and systematic review.犬骨肉瘤的免疫治疗:历史回顾与系统评价
J Vet Intern Med. 2015 May-Jun;29(3):759-69. doi: 10.1111/jvim.12603. Epub 2015 Apr 30.